These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37059222)

  • 1. Clinical pharmacological considerations in an early intravenous to oral antibiotic switch: are barriers real or simply perceived?
    Landersdorfer CB; Gwee A; Nation RL
    Clin Microbiol Infect; 2023 Sep; 29(9):1120-1125. PubMed ID: 37059222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early switch from intravenous to oral antibiotic treatment in bone and joint infections.
    Sendi P; Lora-Tamayo J; Cortes-Penfield NW; Uçkay I
    Clin Microbiol Infect; 2023 Sep; 29(9):1133-1138. PubMed ID: 37182643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study.
    de Graaf H; Sukhtankar P; Arch B; Ahmad N; Lees A; Bennett A; Spowart C; Hickey H; Jeanes A; Armon K; Riordan A; Herberg J; Hackett S; Gamble C; Shingadia D; Pallett A; Clarke SC; Henman P; Emonts M; Sharland M; Finn A; Pollard AJ; Powell C; Marsh P; Ballinger C; Williamson PR; Clarke NM; Faust SN
    Health Technol Assess; 2017 Sep; 21(48):1-164. PubMed ID: 28862129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines.
    McMullan BJ; Andresen D; Blyth CC; Avent ML; Bowen AC; Britton PN; Clark JE; Cooper CM; Curtis N; Goeman E; Hazelton B; Haeusler GM; Khatami A; Newcombe JP; Osowicki J; Palasanthiran P; Starr M; Lai T; Nourse C; Francis JR; Isaacs D; Bryant PA;
    Lancet Infect Dis; 2016 Aug; 16(8):e139-52. PubMed ID: 27321363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations.
    Slavik RS; Jewesson PJ
    Clin Pharmacokinet; 2003; 42(9):793-817. PubMed ID: 12882587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP.
    Engel MF; Postma DF; Hulscher ME; Teding van Berkhout F; Emmelot-Vonk MH; Sankatsing S; Gaillard CA; Bruns AH; Hoepelman AI; Oosterheert JJ
    Eur Respir J; 2013 Jan; 41(1):123-30. PubMed ID: 22653769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAIN study: a protocol for a randomised controlled trial evaluating efficacy, safety and cost-effectiveness of intravenous-to-oral antibiotic switch therapy in neonates with a probable bacterial infection.
    Keij FM; Kornelisse RF; Hartwig NG; Mauff K; Poley MJ; Allegaert K; Reiss IKM; Tramper-Stranders GA
    BMJ Open; 2019 Jul; 9(7):e026688. PubMed ID: 31289068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early switch to oral antimicrobials in brain abscess: a narrative review.
    Bodilsen J; Nielsen H
    Clin Microbiol Infect; 2023 Sep; 29(9):1139-1143. PubMed ID: 37119987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early switch from intravenous to oral antibiotic treatment].
    Buhl CA; Boel JB; Knudsen JD; Horwitz H
    Ugeskr Laeger; 2020 Nov; 182(48):. PubMed ID: 33269686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus intravenous antibiotics for bone and joint infections: the OVIVA non-inferiority RCT.
    Scarborough M; Li HK; Rombach I; Zambellas R; Walker AS; McNally M; Atkins B; Kümin M; Lipsky BA; Hughes H; Bose D; Warren S; Mack D; Folb J; Moore E; Jenkins N; Hopkins S; Seaton RA; Hemsley C; Sandoe J; Aggarwal I; Ellis S; Sutherland R; Geue C; McMeekin N; Scarborough C; Paul J; Cooke G; Bostock J; Khatamzas E; Wong N; Brent A; Lomas J; Matthews P; Wangrangsimakul T; Gundle R; Rogers M; Taylor A; Thwaites GE; Bejon P
    Health Technol Assess; 2019 Aug; 23(38):1-92. PubMed ID: 31373271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of antimicrobial stewardship interventions on early switch from intravenous-to-oral antimicrobials in hospitalized adults: A systematic review.
    Garwan YM; Alsalloum MA; Thabit AK; Jose J; Eljaaly K
    Am J Infect Control; 2023 Jan; 51(1):89-98. PubMed ID: 35644293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early switch/early discharge opportunities for hospitalized patients with methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections in Brazil.
    Furtado GH; Rocha J; Hayden R; Solem C; Macahilig C; Tang WY; Chambers R; Figueiredo MLN; Johnson C; Stephens J; Haider S
    Braz J Infect Dis; 2019; 23(2):86-94. PubMed ID: 31078574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antibiotics for neonatal infections: a systematic review and meta-analysis.
    Keij FM; Kornelisse RF; Hartwig NG; Reiss IKM; Allegaert K; Tramper-Stranders GA
    J Antimicrob Chemother; 2019 Nov; 74(11):3150-3161. PubMed ID: 31236572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.
    Eckmann C; Lawson W; Nathwani D; Solem CT; Stephens JM; Macahilig C; Simoneau D; Hajek P; Charbonneau C; Chambers R; Li JZ; Haider S
    Int J Antimicrob Agents; 2014 Jul; 44(1):56-64. PubMed ID: 24928311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from intravenous to oral antimicrobial therapy in patients with uncomplicated and complicated bloodstream infections.
    Al-Hasan MN; Rac H
    Clin Microbiol Infect; 2020 Mar; 26(3):299-306. PubMed ID: 31128289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving antimicrobial prescribing: implementation of an antimicrobial i.v.-to-oral switch policy.
    McCallum AD; Sutherland RK; Mackintosh CL
    J R Coll Physicians Edinb; 2013; 43(4):294-300. PubMed ID: 24350310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S; Smith S; Newman D; Ritter W; Burke J; Ramirez JA
    Pharmacotherapy; 1997; 17(3):569-75. PubMed ID: 9165561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.